Skip to main content

Table 2 Baseline and day 5 comparisons: primary and relevant secondary outcome measures

From: Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial

  Active (n = 19) Placebo (n = 17)
Day 0 Day 5 Day 0 Day 5
Mean SD Mean SD Mean SD Mean SD
NPI hallucinations subscale 4.42 2.80 2.84 1.74 4.47 3.16 3.12 3.31
CAMCOG 60.05 22.92 59.00 27.23 58.24 21.39 55.12 22.85
MMSE 18.16 6.56 17.42 6.58 17.88 6.06 15.24 6.98
CAF 6.32 3.92 2.95 3.32 5.65 2.55 2.65 2.62
ODFAS 4.58 3.39 3.58 3.04 4.71 2.97 2.71 3.48
TMS phosphene threshold (% output) 73.69 21.83 84.31 23.15 78.88 27.94 89.65 16.33
CGI-I N/A 3.42 1.26 N/A 3.35 0.93
  1. SD standard deviation, NPI Neuropsychiatric Inventory, CAMCOG Cambridge Cognitive Examination, MMSE Mini Mental State Examination, CAF Clinical Assessment of Fluctuation, ODFAS One Day Fluctuation Scale, TMS transcranial magnetic stimulation, N/A not applicable, CGI-I Clinical Global Impression Scale (Improvement)
\